Abstract
This article analyses the law relating to withholding and withdrawing life-prolonging medical treatment in Germany and England & Wales. Recent case law from both jurisdictions is considered and contrasted with jurisprudence from the United States of America. Whilst all three jurisdictions recognise the ability of a competent patient to refuse life-prolonging treatment, it is argued that the models of decision-making adopted in relation to patients lacking capacity are inherently flawed. It is suggested that where the patient lacks capacity, neither the autonomy model of decision-making (encompassing the presumed will approach adopted in Germany and the substituted judgement approach adopted in the USA), nor the best interests model (adopted in England & Wales) can adequately protect the interests (particularly the ‘critical’ interests) of the affected individual.
| Translated title of the contribution | Non-admission and discontinuation of medical treatment at the end of life in Germany and England |
|---|---|
| Original language | German |
| Pages (from-to) | 752-763 |
| Number of pages | 12 |
| Journal | Juristen Zeitung |
| Volume | 57 |
| Issue number | 15/16 |
| Publication status | Published - 9 Aug 2002 |
| Externally published | Yes |
Fingerprint
Dive into the research topics of 'Non-admission and discontinuation of medical treatment at the end of life in Germany and England'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver